Citation: O. Alsmadi et Sa. Tilley, ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY DIRECTED AGAINST CELLS EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE OF PRIMARY OR LABORATORY-ADAPTED STRAINS BY HUMAN AND CHIMPANZEE MONOCLONAL-ANTIBODIES OFDIFFERENT EPITOPE SPECIFICITIES, Journal of virology, 72(1), 1998, pp. 286-293
Authors:
ALSMADI O
HERZ R
MURPHY E
PINTER A
TILLEY SA
Citation: O. Alsmadi et al., A NOVEL ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY EPITOPE IN GP120 IS IDENTIFIED BY 2 MONOCLONAL-ANTIBODIES ISOLATED FROM A LONG-TERM SURVIVOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, Journal of virology, 71(2), 1997, pp. 925-933
Authors:
UGOLINI S
MONDOR I
PARREN PWHI
BURTON DR
TILLEY SA
KLASSE PJ
SATTENTAU QJ
Citation: S. Ugolini et al., INHIBITION OF VIRUS ATTACHMENT TO CD4(-CELLS IS A MAJOR MECHANISM OF T-CELL LINE-ADAPTED HIV-1 NEUTRALIZATION() TARGET), The Journal of experimental medicine, 186(8), 1997, pp. 1287-1298
Authors:
PINCUS SH
WEHRLY K
COLE R
FANG H
LEWIS GK
MCCLURE J
CONLEY AJ
WAHREN B
POSNER MR
NOTKINS AL
TILLEY SA
PINTER A
EIDEN L
TEINTZE M
DORWARD D
TOLSTIKOV VV
Citation: Sh. Pincus et al., IN-VITRO EFFECTS OF ANTI-HIV IMMUNOTOXINS DIRECTED AGAINST MULTIPLE EPITOPES ON HIV TYPE-1 ENVELOPE GLYCOPROTEIN-160, AIDS research and human retroviruses, 12(11), 1996, pp. 1041-1051
Authors:
VIJHWARRIER S
PINTER A
HONNEN WJ
TILLEY SA
Citation: S. Vijhwarrier et al., SYNERGISTIC NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY A CHIMPANZEE MONOCLONAL-ANTIBODY AGAINST THE V2 DOMAIN OF GP120 IN COMBINATION WITH MONOCLONAL-ANTIBODIES AGAINST THE V3 LOOP AND THE CD4-BINDING SITE, Journal of virology, 70(7), 1996, pp. 4466-4473
Citation: S. Demaria et al., BATHOPHENANTHROLINE DISULFONATE AND SOLUBLE CD4 AS PROBES FOR EARLY EVENTS OF HIV TYPE-1 ENTRY, AIDS research and human retroviruses, 11(1), 1995, pp. 127-139
Citation: Sa. Tilley et S. Vijhwarrier, SYNERGISTIC NEUTRALIZATION OF HIV-1 BY MONOCLONAL-ANTIBODIES DIRECTEDAGAINST THE V2 DOMAIN, V3 LOOP, AND CD4-BINDING SITE OF GP120, Journal of cellular biochemistry, 1995, pp. 227-227
Authors:
VIJHWARRIER S
MURPHY E
YOKOYAMA I
TILLEY SA
Citation: S. Vijhwarrier et al., CHARACTERIZATION OF THE VARIABLE REGIONS OF CHIMPANZEE MONOCLONAL-ANTIBODY WITH POTENT NEUTRALIZING ACTIVITY AGAINST HIV-1 (VOL 32, PG 1081, 1995), Molecular immunology, 32(17-18), 1995, pp. 1455-1455
Authors:
VIJHWARRIER S
MURPHY E
YOKOYAMA I
TILLEY SA
Citation: S. Vijhwarrier et al., CHARACTERIZATION OF THE VARIABLE REGIONS OF A CHIMPANZEE MONOCLONAL-ANTIBODY WITH POTENT NEUTRALIZING ACTIVITY AGAINST HIV-1, Molecular immunology, 32(14-15), 1995, pp. 1081-1092
Authors:
WU Z
KAYMAN SC
HONNEN W
REVESZ K
CHEN H
VIJHWARRIER S
TILLEY SA
MCKEATING J
SHOTTON C
PINTER A
Citation: Z. Wu et al., CHARACTERIZATION OF NEUTRALIZATION EPITOPES IN THE V2 REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I GP120 - ROLE OF GLYCOSYLATION IN THE CORRECT FOLDING OF THE V1 V2 DOMAIN/, Journal of virology, 69(4), 1995, pp. 2271-2278
Authors:
WARRIER SV
PINTER A
HONNEN WJ
GIRARD M
MUCHMORE E
TILLEY SA
Citation: Sv. Warrier et al., A NOVEL, GLYCAN-DEPENDENT EPITOPE IN THE V2 DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GYR120 IS RECOGNIZED BY A HIGHLY POTENT, NEUTRALIZING CHIMPANZEE MONOCLONAL-ANTIBODY, Journal of virology, 68(7), 1994, pp. 4636-4642
Authors:
TILLEY SA
HONNEN WJ
WARRIER S
RACHO M
ALSMADI O
HERZ R
PINTER A
Citation: Sa. Tilley et al., EPITOPES OF HUMAN AND CHIMPANZEE MONOCLONAL-ANTIBODIES (MABS) WITH ANTIVIRAL ACTIVITY AGAINST HIV-1, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 679-679
Citation: A. Pinter et al., A POTENT, NEUTRALIZING HUMAN MONOCLONAL-ANTIBODY AGAINST A UNIQUE EPITOPE OVERLAPPING THE CD4-BINDING SITE OF HIV-1 GP120 THAT IS BROADLY CONSERVED ACROSS NORTH-AMERICAN AND AFRICAN VIRUS ISOLATES, AIDS research and human retroviruses, 9(10), 1993, pp. 985-996
Citation: A. Pinter et al., CONFORMATIONAL-CHANGES AFFECTING THE V3 AND CD4-BINDING DOMAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ASSOCIATED WITH ENV PROCESSINGAND WITH BINDING OF LIGANDS TO THESE SITES, Journal of virology, 67(9), 1993, pp. 5692-5697